Philip C. Craven - Concepedia

Author

Philip C. Craven

Murphy Oil Corporation (United States)

Also Known As

P C Craven, P. C. Craven, P.C. Craven, PHILIP C. CRAVEN, Philip C. Craven, Philip C. Craven

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Murphy Oil Corporation (United States)The University of Texas Health Science Center at San Antonio Audie L. Murphy Memorial VA Hospital Santa Clara Valley Medical Center The University of Texas at San Antonio

About

Philip C. Craven is an author at Murphy Oil Corporation (United States) specializing in medicine, infection control, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	461
2	Health Sciences	5	5	220
3	Public Health	1	1	21
4	Emergency Medicine	1	1	20
5	Hospital Medicine	1	1	21

Philip C. Craven

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Treatment of Cryptococcal Meningitis with Combination Amphotericin B and Flucytosine for Four as Compared with Six Weeks William E. Dismukes, Gretchen A. Cloud, Harry A. Gallis, New England Journal of Medicine	1987	415
Treatment of Murine Cryptococcosis with Liposome-Associated Amphotericin B John R. Graybill, Philip C. Craven, Robert L. Taylor, The Journal of Infectious Diseases	1982	200
Amphotericin B in Liposomes: A Novel Therapy for Histoplasmosis <sup>1</sup> R L Taylor, David Williams, Philip C. Craven, American Review of Respiratory Disease	1982	157
Pharmacology and toxicity of high-dose ketoconazole Alan M. Sugar, S G Alsip, J N Galgiani, Antimicrobial Agents and Chemotherapy	1987	131
A Cluster of Rhodococcus (Gordona) Bronchialis Sternal-Wound Infections after Coronary-Artery Bypass Surgery Hervé Richet, Philip C. Craven, June M. Brown, New England Journal of Medicine Pathogenic MicrobiologyPathologyRhodococcus SpeciesBacterial PathogensBronchialis Infection	1991	123
High-Dose Ketoconazole for Treatment of Fungal Infections of the Central Nervous System Philip C. Craven Annals of Internal Medicine	1983	101
Excretion Pathways of Amphotericin B Philip C. Craven, Thomas M. Ludden, David J. Drutz, The Journal of Infectious Diseases	1979	85
Toxoplasmosis presenting as panhypopituitarism in a patient with the acquired immune deficiency syndrome Shawn A. Milligan, Michael Katz, Philip C. Craven, The American Journal of Medicine Autoimmune DiseaseImmunodeficienciesImmunologyPathologyAutoimmunity	1984	82
Risk factors of ventricular fibrillation during rapid amphotericin B infusion Philip C. Craven, David H. Gremillion Antimicrobial Agents and Chemotherapy Electrolyte DisorderHeart FailureCardiovascular PharmacologyPharmacotherapyPharmacokinetics	1985	71
Oral ciprofloxacin therapy for chronic contiguous osteomyelitis caused by aerobic gram-negative bacilli. David N. Gilbert, Alan D. Tice, Peter K. Marsh, PubMed	1987	64

Page 1